NAMS
NewAmsterdam Pharma Company N.V.
23.80$
+1.0%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | -51.4% | +603.8% | -27.5% | +149.1% | -11.0% | |
| – | +3,482.9% | +613.9% | -27.4% | +149.0% | -21.7% | |
| – | +4,323.1% | +674.6% | -27.2% | +126.7% | -36.5% | |
| – | +4,323.1% | +674.6% | -27.2% | +145.0% | -23.7% | |
| – | – | -62.4% | -9.1% | +1,032.6% | +8.7% | |
| – | – | – | -8,050.1% | – | – | |
| – | +1,483.3% | – | – | – | – | |
| – | – | – | – | – | – | |
| – | – | – | -18.3% | +214.1% | -23.8% | |
| – | -8.4% | +326.2% | +21.2% | +82.5% | -19.9% | |
| – | +4,650.6% | +220.9% | +38.4% | +114.3% | -19.8% | |
| – | -99.5% | +9.5% | -9.1% | +310.0% | -44.7% | |
| – | +4,253.7% | +67.6% | +42.8% | -72.0% | +89.1% | |
| – | -55.6% | +659.5% | -32.9% | +162.7% | -9.8% | |
| – | -95,234.0% | – | – | – | – | |
| – | +0.0% | +6.8% | +333.2% | +14.8% | +21.2% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.